title: [Efficacy of hospital at home (HaH) in the treatment of community-acquired pneumonia (CAP) with different degrees of severity].
abstract: OBJECTIVE
  Different scientific societies propose the use of scales of severity and additional criteria (AC) in order to determine the setting for the treatment of Community-Acquired Pneumonia (CAP).The objective of this study is to correlate the risk regarding three clinical prediction rules (PSI, CURB-65 and PSCRUXO-80) and AC with the effectiveness of hospital at home (HaH).
  
  
  METHODS
  Evaluation of cases of CAP referred from the Emergency Unit to HaH between January 2000 and May 2008. They were classified regarding three risk scales and presence of AC and its association with the effectiveness of HaH during the treatment was analysed.
  
  
  RESULTS
  146 women and 181 men were admitted, (mean age, 60.3 years). The average stay in HaH was 8.6 days. Two patients died, 25 (7.7%) were admitted to hospital, 219 progressed favourably throughout and 81 after overcoming complications. Hospital at Home was effective in 92.3% of total patients. The rate was 85% for those in PSI=IV or V with or without additional criteria; 80% for CURB-65=2 and 77.5% for a PSCURXO-80 score of 10-19. The effectiveness of HaH is inversely related to severity.
  
  
  CONCLUSIONS
  Hospital a Home (HaD) is an effective and safe care option for many cases of CAP in which hospital admission is normally recommended on the basis of prediction rule scores or additional admission criteria.
authors.affiliation: Unidad de Hospitalización a Domicilio de Vitoria-Gasteiz, Hospital Txagorritxu y Hospital Santiago Apóstol, Vitoria-Gasteiz, España. jose.regaladodeloscobos@osakidetza.net
authors.forename: José
authors.initials: J
authors.lastname: Regalado de Los Cobos
authors.forename: Felipe
authors.initials: F
authors.lastname: Aizpuru Barandiaran
authors.forename: Esther
authors.initials: E
authors.lastname: Oceja Barrutieta
authors.forename: María
authors.initials: M
authors.lastname: de Juan Rodríguez
authors.forename: Leire
authors.initials: L
authors.lastname: Apraiz Ruiz
authors.forename: Elena
authors.initials: E
authors.lastname: Altuna Basurto
authors.forename: Montserrat
authors.initials: M
authors.lastname: Gomez Rodríguez de Mendarozqueta
authors.forename: Amanda
authors.initials: A
authors.lastname: López-Picado
authors.forename: Juan Miguel
authors.initials: JM
authors.lastname: Cia Ruiz
mesh_terms: D000328:Adult; D000368:Aged; D000900:Anti-Bacterial Agents / Q000627:therapeutic use; D017714:Community-Acquired Infections / Q000188:drug therapy / Q000401:mortality / Q000451:nursing / Q000628:therapy*; D005260:Female; D018575:Home Care Services, Hospital-Based / Q000706:statistics & numerical data; D006760:Hospitalization / Q000706:statistics & numerical data; D006801:Humans; D008297:Male; D008875:Middle Aged; D010348:Patient Care Team; D010359:Patient Readmission / Q000706:statistics & numerical data; D011014:Pneumonia / Q000188:drug therapy / Q000401:mortality / Q000451:nursing / Q000628:therapy*; D015397:Program Evaluation; D012189:Retrospective Studies; D018570:Risk Assessment; D012720:Severity of Illness Index; D013030:Spain
chemical_list: D000900:Anti-Bacterial Agents